Fig. 1: CONSORT flow diagram for each bamlanivimab dose cohort.

A 7000 mg dose cohort and B 700 mg dose cohort. ^aOf the n = 48 participants that received bamlanivimab 7000 mg, one participant was assigned to bamlanivimab 700 mg, but received bamlanivimab 7000 mg. ^bOf the n = 111 participants that received bamlanivimab 700 mg, 2 participants were assigned bamlanivimab 7000 mg, but received bamlanivimab 700 mg. ^cOf the n = 112 participants that received placebo for bamlanivimab 700 mg, 2 participants were assigned placebo for bamlanivimab 7000 mg (the placebo was the same for both bamlanivimab 7000 mg and 700 mg, normal saline).